Circulating HIV-1-specific IL-21+ Tfh cells were found at higher frequencies in sera from participants in the partially protective ALVAC+AIDSVAX (RV144) HIV/AIDS clinical trial compared to the non-protective DNA+Ad5 clinical trial, thus correlating protective antibody responses with elevated percentages of this CD4+ T cell subtype [69]. Here, CD4 is linked to AIDS.